Live Breaking News & Updates on Silverstein Foundation For Parkinson

Stay updated with breaking news from Silverstein foundation for parkinson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Gain Therapeutics Announces Positive Results from the Single Ascending Dose (SAD) Part of the Phase 1 Clinical Trial of GT-02287, a Novel GCase-Targeting Small Molecule Therapy for GBA1 Parkinson's Disease

BETHESDA, Md., April 24, 2024 Gain Therapeutics, Inc. , a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule. ....

Jonas Hannestad , Matthias Alder , Elio Ambrosio , Nic Johnson , Swiss Innovation Agency , European Union Horizon , Exchange Commission On , Company Annual Report On Form , Michaelj Fox Foundation For Parkinson Research , Bellberry Human Research Ethics Committee , Silverstein Foundation For Parkinson , Exchange Commission , Gain Therapeutics Inc , Gain Chief Medical Officer Jonas , Silverstein Foundation , Swiss Innovation , Gain Therapeutics , Site Directed Enzyme Enhancement Therapy , Private Securities Litigation Reform Act , Annual Report ,

Gain Therapeutics Announces Positive Results from the

BETHESDA, Md., April 24, 2024 (GLOBE NEWSWIRE) Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology. ....

Jonas Hannestad , Matthias Alder , Elio Ambrosio , Nic Johnson , Company Annual Report On Form , European Union Horizon , Silverstein Foundation For Parkinson , Exchange Commission On , Michaelj Fox Foundation For Parkinson Research , Swiss Innovation Agency , Exchange Commission , Gain Therapeutics Inc , Bellberry Human Research Ethics Committee , Gain Chief Medical Officer Jonas , Silverstein Foundation , Swiss Innovation , Gain Therapeutics , Site Directed Enzyme Enhancement Therapy , Private Securities Litigation Reform Act , Annual Report , Nasdaq Ganx , Gain Therapeutics , T 02287 , Arkinson 39 Sdisease ,

Gain Therapeutics (GANX) Announces Positive Results from the Single Ascending Dose (SAD) Part of the Phase 1 Clinical Trial of GT-02287

Gain Therapeutics (GANX) Announces Positive Results from the Single Ascending Dose (SAD) Part of the Phase 1 Clinical Trial of GT-02287
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Jonas Hannestad , Matthias Alder , Gain Therapeutics Inc , Silverstein Foundation For Parkinson , Bellberry Human Research Ethics Committee , Michaelj Fox Foundation For Parkinson Research , European Union Horizon , Swiss Innovation Agency , Gain Therapeutics , Gain Chief Medical Officer Jonas , Silverstein Foundation , Swiss Innovation , Site Directed Enzyme Enhancement Therapy ,

Gain Therapeutics Bolsters Management Team with the Appointment of Gene Mack as Chief Financial Officer

BETHESDA, Md., April 08, 2024 Gain Therapeutics, Inc. , a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule. ....

Elio Ambrosio , Nic Johnson , Matthias Alder , Gruntal Co , Exchange Commission , European Union Horizon , Swiss Innovation Agency , Gain Therapeutics Inc , Fordham University , Michaelj Fox Foundation For Parkinson Research , Exchange Commission On , Merck Co , Company Annual Report On Form , Silverstein Foundation For Parkinson , Gene Mack , Gain Therapeutics , Equity Incentive Plan , Nasdaq Listing Rule , Initial Vesting Date , Silverstein Foundation , Swiss Innovation , Site Directed Enzyme Enhancement Therapy , Private Securities Litigation Reform Act , Annual Report ,

Gain Therapeutics Bolsters Management Team with the

BETHESDA, Md., April 08, 2024 (GLOBE NEWSWIRE) Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology. ....

Elio Ambrosio , Matthias Alder , Nic Johnson , Exchange Commission On , Company Annual Report On Form , Silverstein Foundation For Parkinson , European Union Horizon , Michaelj Fox Foundation For Parkinson Research , Gain Therapeutics Inc , Gruntal Co , Swiss Innovation Agency , Exchange Commission , Fordham University , Merck Co , Gene Mack , Gain Therapeutics , Equity Incentive Plan , Nasdaq Listing Rule , Initial Vesting Date , Silverstein Foundation , Swiss Innovation , Site Directed Enzyme Enhancement Therapy , Private Securities Litigation Reform Act , Annual Report , Nasdaq Ganx , Gain Therapeutics ,